{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:00:41Z","timestamp":1786546841534,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05334-7","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T01:17:23Z","timestamp":1786497443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic regulation of tubular epithelial cell dysfunction in diabetic kidney disease"],"prefix":"10.1007","author":[{"given":"Hanxue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"5","key":"5334_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70098","volume":"17","author":"Y He","year":"2025","unstructured":"He Y, Wang X, Li L, Liu M, Wu Y, Chen R, He J, Mai W, Li X (2025) Global, regional, and national prevalence of chronic type 2 diabetic kidney disease from 1990\u20132021: a trend and health inequality analyses based on the global burden of disease study 2021. J Diabetes 17(5):e70098","journal-title":"J Diabetes"},{"issue":"6","key":"5334_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13061424","volume":"13","author":"J Geng","year":"2025","unstructured":"Geng J, Ma S, Tang H, Zhang C (2025) Pathogenesis and therapeutic perspectives of tubular injury in diabetic kidney disease: an update. Biomedicines 13(6):1424","journal-title":"Biomedicines"},{"key":"5334_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1238927","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Jin M, Cheng CK, Li Q (2023) Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives. Front Endocrinol (Lausanne) 14:1238927","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"5334_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41419-024-06833-0","volume":"15","author":"X Fan","year":"2024","unstructured":"Fan X, Yang M, Lang Y, Lu S, Kong Z, Gao Y, Shen N, Zhang D, Lv Z (2024) Mitochondrial metabolic reprogramming in diabetic kidney disease. Cell Death Dis 15(6):442","journal-title":"Cell Death Dis"},{"issue":"10","key":"5334_CR5","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1038\/s12276-023-01095-w","volume":"55","author":"YJ An","year":"2023","unstructured":"An YJ, Jo S, Kim JM, Kim HS, Kim HY, Jeon SM, Han D, Yook JI, Kang KW, Park S (2023) Lactate as a major epigenetic carbon source for histone acetylation via nuclear LDH metabolism. Exp Mol Med 55(10):2238\u20132247","journal-title":"Exp Mol Med"},{"issue":"11","key":"5334_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168825","volume":"9","author":"M Darshi","year":"2024","unstructured":"Darshi M, Kugathasan L, Maity S et al (2024) Glycolytic lactate in diabetic kidney disease. JCI Insight 9(11):e168825","journal-title":"JCI Insight"},{"issue":"11","key":"5334_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3390\/cimb47110885","volume":"47","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang C, Fu Y, Xie L, Kong Y, Yang X (2025) Inflammation, apoptosis, and fibrosis in diabetic nephropathy: molecular crosstalk in proximal tubular epithelial cells and therapeutic implications. Curr Issues Mol Biol 47(11):885","journal-title":"Curr Issues Mol Biol"},{"key":"5334_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12964-023-01323-w","volume":"21","author":"S Jiang","year":"2023","unstructured":"Jiang S, Su H (2023) Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease. Cell Commun Signal 21:288","journal-title":"Cell Commun Signal"},{"issue":"13","key":"5334_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137452","volume":"23","author":"C Magkrioti","year":"2022","unstructured":"Magkrioti C, Antonopoulou G, Fanidis D, Pliaka V, Sakellaropoulos T, Alexopoulos LG, Ullmer C, Aidinis V (2022) Lysophosphatidic acid is a proinflammatory stimulus of renal tubular epithelial cells. Int J Mol Sci 23(13):7452","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5334_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3596","volume":"39","author":"X Zhou","year":"2023","unstructured":"Zhou X, Xu C, Dong J, Liao L (2023) Role of renal tubular programed cell death in diabetic kidney disease. Diabetes Metab Res Rev 39(2):e3596","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"5334_CR11","doi-asserted-by":"publisher","first-page":"2529618","DOI":"10.1080\/13510002.2025.2529618","volume":"30","author":"X Liu","year":"2025","unstructured":"Liu X, Chen C, Zhu S, Luo X, Gao L, Hu Z, Ma Y, Jiang L, Wu Y (2025) ACSF2-PGK1 interaction promotes ferroptosis in renal tubular epithelial cells of diabetic nephropathy by regulating Keap1\/Nrf2 signaling. Redox Rep 30(1):2529618","journal-title":"Redox Rep"},{"issue":"6","key":"5334_CR12","first-page":"940","volume":"50","author":"J Yang","year":"2025","unstructured":"Yang J, Luo Y, Zhu Z, Tang W (2025) ANXA2 and NF-\u03baB positive feedback loop promotes high glucose-induced pyroptosis in renal tubular epithelial cells. J Cent South Univ Med Sci 50(6):940\u2013954","journal-title":"J Cent South Univ Med Sci"},{"issue":"1","key":"5334_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00125-022-05810-6","volume":"66","author":"XP Zhao","year":"2023","unstructured":"Zhao XP, Chang SY, Pang Y, Liao MC, Peng JZ, Ingelfinger JR, Chan JSD, Zhang SL (2023) Hedgehog interacting protein activates sodium\u2013glucose cotransporter 2 expression and promotes renal tubular epithelial cell senescence in a mouse model of type 1 diabetes. Diabetologia 66(1):223\u2013240","journal-title":"Diabetologia"},{"issue":"5","key":"5334_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ajpath.2025.01.011","volume":"195","author":"M Kha","year":"2025","unstructured":"Kha M, Magnusson Y, Johansson I, Altiparmak G, Lundgren J, Nystr\u00f6m J, Ebefors K, Sw\u00e4rd K, Johansson ME (2025) Injured proximal tubular epithelial cells lose hepatocyte nuclear factor 4\u03b1 expression crucial for brush border formation and transport. Am J Pathol 195(5):845\u2013860","journal-title":"Am J Pathol"},{"issue":"5","key":"5334_CR15","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1039\/D3CS00858D","volume":"53","author":"E Kriukien\u0117","year":"2024","unstructured":"Kriukien\u0117 E, Tomkuvien\u0117 M, Klima\u0161auskas S (2024) 5-Hydroxymethylcytosine: the many faces of the sixth base of mammalian DNA. Chem Soc Rev 53(5):2264\u20132283","journal-title":"Chem Soc Rev"},{"issue":"9","key":"5334_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/biom14091117","volume":"14","author":"AT Davletgildeeva","year":"2024","unstructured":"Davletgildeeva AT, Kuznetsov NA (2024) The role of DNMT methyltransferases and TET dioxygenases in the maintenance of the DNA methylation level. Biomolecules 14(9):1117","journal-title":"Biomolecules"},{"issue":"3","key":"5334_CR17","doi-asserted-by":"publisher","first-page":"F397","DOI":"10.1152\/ajprenal.00124.2024","volume":"327","author":"T Marumo","year":"2024","unstructured":"Marumo T, Yoshida N, Inoue N, Yamanouchi M, Ubara Y, Urakami S, Fujii T, Takazawa Y, Ohashi K, Kawarazaki W, Nishimoto M, Ayuzawa N, Hirohama D, Nagae G, Fujimoto M, Arai E, Kanai Y, Hoshino J, Fujita T (2024) Aberrant proximal tubule DNA methylation underlies phenotypic changes related to kidney dysfunction in patients with diabetes. Am J Physiol Renal Physiol 327(3):F397\u2013F411","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"5334_CR18","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1681\/ASN.2014070665","volume":"26","author":"T Marumo","year":"2015","unstructured":"Marumo T, Yagi S, Kawarazaki W, Nishimoto M, Ayuzawa N, Watanabe A, Ueda K, Hirahashi J, Hishikawa K, Sakurai H, Shiota K, Fujita T (2015) Diabetes induces aberrant DNA methylation in the proximal tubules of the kidney. J Am Soc Nephrol 26(10):2388\u20132397","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5334_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-06713-3","volume":"15","author":"L Qu","year":"2025","unstructured":"Qu L, Wang T, Kong J, Wu X, Li Q, Long T, An X, Lu Y, Mu Y, Ran Y, Guo B, Shi M (2025) DNMT3B aggravated renal fibrosis in diabetic kidney disease via activating Wnt\/\u03b2-catenin signaling pathway. Sci Rep 15(1):21070","journal-title":"Sci Rep"},{"issue":"5","key":"5334_CR20","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202504594R","volume":"40","author":"X Zhang","year":"2026","unstructured":"Zhang X, Song Y, Huang X, Wang X, Yuan W, Zhu N (2026) Inhibition of DNA methyltransferase 1 ameliorates renal injuries in diabetic nephropathy by targeting NF2. FASEB J 40(5):e71624","journal-title":"FASEB J"},{"key":"5334_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41392-023-01528-y","volume":"8","author":"R Liu","year":"2023","unstructured":"Liu R, Zhao E, Yu H, Yuan C, Abbas MN, Cui H (2023) Methylation across the central dogma in health and diseases: new therapeutic strategies. Signal Transduct Target Ther 8:310","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"5334_CR22","volume":"38","author":"J Wang","year":"2024","unstructured":"Wang J, Li Y, Zhang Y, Li S, Wang Y, Zhang L, Xu Y, Li X (2024) DNA methylation-mediated regulation of renal tubular epithelial cell injury in diabetic kidney disease. FASEB J 38(6):e23552","journal-title":"FASEB J"},{"key":"5334_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123936","volume":"380","author":"S Gao","year":"2025","unstructured":"Gao S, Xiao H, Luo H, Tang X, Zeng Y (2025) Histone acetylation: a key regulator of inflammatory responses. Life Sci 380:123936","journal-title":"Life Sci"},{"issue":"4","key":"5334_CR24","doi-asserted-by":"publisher","first-page":"757","DOI":"10.37349\/etat.2023.00166","volume":"4","author":"DI Abdallah","year":"2023","unstructured":"Abdallah DI, de Araujo ED, Patel NH, Hasan LS, Moriggl R, Kr\u00e4mer OH, Gunning PT (2023) Medicinal chemistry advances in targeting class I histone deacetylases. Explor Target Antitumor Ther 4(4):757\u2013779","journal-title":"Explor Target Antitumor Ther"},{"issue":"5","key":"5334_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ph17050620","volume":"17","author":"A Curcio","year":"2024","unstructured":"Curcio A, Rocca R, Alcaro S, Artese A (2024) The histone deacetylase family: structural features and application of combined computational methods. Pharmaceuticals (Basel) 17(5):620","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"5334_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/15376516.2014.920448","volume":"24","author":"Y Tian","year":"2014","unstructured":"Tian Y, Yang Y, Gao L, Zhao H, Peng X, Zhang Z, Wu G (2014) Expression of histone deacetylase-1 and p300 in aristolochic acid nephropathy models. Toxicol Mech Methods 24(6):377\u2013384","journal-title":"Toxicol Mech Methods"},{"issue":"7","key":"5334_CR27","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1096\/fj.201801067RR","volume":"33","author":"C Xiong","year":"2019","unstructured":"Xiong C, Guan Y, Zhou X, Liu L, Zhuang MA, Zhang W, Zhang Y, Masucci MV, Bayliss G, Zhao TC, Zhuang S (2019) Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis. FASEB J 33(7):8249\u20138262","journal-title":"FASEB J"},{"issue":"5","key":"5334_CR28","doi-asserted-by":"publisher","first-page":"F875","DOI":"10.1152\/ajprenal.00499.2018","volume":"316","author":"KA Hyndman","year":"2019","unstructured":"Hyndman KA, Kasztan M, Mendoza LD, Monteiro-Pai S (2019) Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation. Am J Physiol Renal Physiol 316(5):F875\u2013F888","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"5334_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/CS20210470","volume":"136","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Zhang S, Chen J, Zou M, Yang Y, Lu W, Ren S, Wang X, Dong W, Zhang Z, Wang L, Guan M, Cheing GLY, Xue Y, Jia Y (2022) The HDAC2\/SP1\/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease. Clin Sci (Lond) 136(3):223\u2013238","journal-title":"Clin Sci (Lond)"},{"key":"5334_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jare.2025.10.008","volume":"85","author":"Q Jin","year":"2026","unstructured":"Jin Q, Li L, Qu P, Ma F, Li P, Qiao Y, Zhang Y, Ran S, Li X, Liu T, Yang L, Li Q, Mao H, Wang Y, Ren F, Zhan Y, Peng L (2026) Mitigation of renal tubular injury by SIRT6 may improve individual outcomes in diabetic kidney disease-potential mechanisms involving epigenetic repression of inflammatory responses. J Adv Res 85:281\u2013294","journal-title":"J Adv Res"},{"issue":"12","key":"5334_CR31","volume":"13","author":"L Reed","year":"2024","unstructured":"Reed L, Abraham J, Patel S, Dhar SS (2024) Epigenetic modifiers: exploring the roles of histone methyltransferases and demethylases in cancer and neurodegeneration. Biology (Basel) 13(12):1008","journal-title":"Biology (Basel)"},{"issue":"1","key":"5334_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13148-025-02010-y","volume":"17","author":"L Yang","year":"2025","unstructured":"Yang L, Li H, Zhao Y, Qian Z, Luo G, Chen X, Yang X (2025) Lysine demethylases 6A and 6B as epigenetic regulators in therapeutic resistance of cancer. Clin Epigenetics 17(1):198","journal-title":"Clin Epigenetics"},{"issue":"6","key":"5334_CR33","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1113\/JP277367","volume":"597","author":"H Chen","year":"2019","unstructured":"Chen H, Huang Y, Zhu X, Liu C, Yuan Y, Su H, Zhang C, Liu C, Xiong M, Qu Y, Yun P, Zheng L, Huang K (2019) Histone demethylase UTX is a therapeutic target for diabetic kidney disease. J Physiol 597(6):1643\u20131660","journal-title":"J Physiol"},{"key":"5334_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8814163","volume":"2021","author":"S Bai","year":"2021","unstructured":"Bai S, Xiong X, Tang B, Ji T, Li X, Qu X, Li W (2021) Hsa-miR-199b-3p prevents the epithelial-mesenchymal transition and dysfunction of the renal tubule by regulating E-cadherin through targeting KDM6A in diabetic nephropathy. Oxid Med Cell Longev 2021:8814163","journal-title":"Oxid Med Cell Longev"},{"key":"5334_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216706","volume":"586","author":"P Kaur","year":"2024","unstructured":"Kaur P, Shankar E, Gupta S (2024) EZH2-mediated development of therapeutic resistance in cancer. Cancer Lett 586:216706","journal-title":"Cancer Lett"},{"issue":"21","key":"5334_CR36","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3390\/cells14211729","volume":"14","author":"L Ludewig","year":"2025","unstructured":"Ludewig L, Bondeva T, Liebisch M, Ihle J, Loeffler I, Wolf G (2025) Advanced glycation end products mediate epigenetic alteration of H3K27me3 in renal proximal tubular cells: potential role in metabolic memory. Cells 14(21):1729","journal-title":"Cells"},{"issue":"9","key":"5334_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202516984","volume":"13","author":"L Li","year":"2026","unstructured":"Li L, Wang Y, Zhang X et al (2026) SETDB2 mitigates podocyte dysfunction in diabetic kidney disease through epigenetic silencing of SMAD3. Adv Sci (Weinh) 13(9):e16984","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5334_CR38","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1159\/000547202","volume":"11","author":"X Du","year":"2025","unstructured":"Du X, Yao L, Zhuang S (2025) Lysine methyltransferases SMYD2 and SMYD3: emerging targets in kidney diseases. Kidney Dis (Basel) 11(1):518\u2013529","journal-title":"Kidney Dis (Basel)"},{"key":"5334_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116331","volume":"225","author":"K Xu","year":"2024","unstructured":"Xu K, Zhang K, Wang Y, Gu Y (2024) Comprehensive review of histone lactylation: structure, function, and therapeutic targets. Biochem Pharmacol 225:116331","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"5334_CR40","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.7150\/ijbs.126011","volume":"22","author":"S Shen","year":"2026","unstructured":"Shen S, Ying C, Fu X, Zeng X, Guo X, Wu H, Zhang L, Xu L (2026) Delactylase effects of SIRT3 on a positive feedback loop involving the RUNX1-glycolysis-histone lactylation in diabetic kidney disease. Int J Biol Sci 22(4):1775\u20131792","journal-title":"Int J Biol Sci"},{"key":"5334_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103246","volume":"75","author":"X Zhang","year":"2024","unstructured":"Zhang X, Chen J, Lin R, Huang Y, Wang Z, Xu S, Wang L, Chen F, Zhang J, Pan K, Yin Z (2024) Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la\/KLF5 pathway. Redox Biol 75:103246","journal-title":"Redox Biol"},{"issue":"1","key":"5334_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","volume":"9","author":"W Yao","year":"2024","unstructured":"Yao W, Hu X, Wang X (2024) Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases. Signal Transduct Target Ther 9(1):232","journal-title":"Signal Transduct Target Ther"},{"key":"5334_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114045","volume":"182","author":"A Wonnacott","year":"2022","unstructured":"Wonnacott A, Denby L, Coward RJM, Fraser DJ, Bowen T (2022) MicroRNAs and their delivery in diabetic fibrosis. Adv Drug Deliv Rev 182:114045","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"5334_CR44","volume":"15","author":"JA Nickerson","year":"2024","unstructured":"Nickerson JA, Momen-Heravi F (2024) Long non-coding RNAs: roles in cellular stress responses and epigenetic mechanisms regulating chromatin. Nucleus (Austin) 15(1):2350180","journal-title":"Nucleus (Austin)"},{"issue":"5","key":"5334_CR45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","volume":"25","author":"J Ferrer","year":"2024","unstructured":"Ferrer J, Dimitrova N (2024) Transcription regulation by long non-coding RNAs: mechanisms and disease relevance. Nat Rev Mol Cell Biol 25(5):396\u2013415","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"5334_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13349","volume":"56","author":"Y Song","year":"2023","unstructured":"Song Y, Guo F, Zhao Y et al (2023) Novel lncRNA-prader willi\/angelman region RNA, SNRPN neighbour (PWARSN) aggravates tubular epithelial cell pyroptosis by regulating TXNIP via dual way in diabetic kidney disease. Cell Prolif 56(2):e13349","journal-title":"Cell Prolif"},{"issue":"3","key":"5334_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/biof.70109","volume":"52","author":"Y Wu","year":"2026","unstructured":"Wu Y, Chen Z, Tang F et al (2026) Circular RNAs in cancer: epigenetic regulation, dual functions and clinical translation. BioFactors 52(3):e70109","journal-title":"BioFactors"},{"issue":"5","key":"5334_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101854","volume":"13","author":"Y Yang","year":"2026","unstructured":"Yang Y, Luo X, Li E, Li Z, Zou F, Liao J, Wu Y, Wei B (2026) Unraveling the role of PIWI\/piRNAs in stem cell therapy: epigenetic mechanisms and therapeutic potentials. Genes Dis 13(5):101854","journal-title":"Genes Dis"},{"issue":"10","key":"5334_CR49","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.3390\/cancers12102773","volume":"12","author":"J Park","year":"2020","unstructured":"Park J, Ahn SH, Shin MG et al (2020) tRNA-derived small RNAs: novel epigenetic regulators. Cancers (Basel) 12(10):2773","journal-title":"Cancers (Basel)"},{"issue":"824","key":"5334_CR50","doi-asserted-by":"publisher","first-page":"eadt5340","DOI":"10.1126\/scitranslmed.adt5340","volume":"17","author":"J Huang","year":"2025","unstructured":"Huang J, Fu X, Zhang R, Wang Z, Qiu F, Chen X, Fan J, Cao C, Xu Y, Li J, Liang Y, He D, Lu A, Liang C (2025) snoRNA Snord3 promotes rheumatoid arthritis by epigenetic regulation of ESM1 in fibroblast-like synoviocytes in mice. Science Translational Medicine 17(824):eadt5340","journal-title":"Science Translational Medicine"},{"key":"5334_CR51","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19940","volume":"13","author":"S Guo","year":"2025","unstructured":"Guo S, Wang W, Lv G, Ling Y, Zhu M (2025) The role of N6-methyladenosine (m6A) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential. PeerJ 13:e19940","journal-title":"PeerJ"},{"issue":"1","key":"5334_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2521455","volume":"47","author":"T Chen","year":"2025","unstructured":"Chen T, Wang J, Xu Y, Zhu Y, Jin Y, Fan Q (2025) METTL3 alleviates renal tubular mitochondrial dysfunction by regulating the TUG1\/PGC-1\u03b1 axis in an IGF2BP2-dependent manner in diabetic nephropathy. Ren Fail 47(1):2521455","journal-title":"Ren Fail"},{"issue":"5","key":"5334_CR53","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antiox12051075","volume":"12","author":"O Abu Shelbayeh","year":"2023","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB (2023) PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants (Basel) 12(5):1075","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"5334_CR54","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1042\/BST20230574","volume":"52","author":"G Wei","year":"2024","unstructured":"Wei G (2024) RNA m6A modification, signals for degradation or stabilisation? Biochem Soc Trans 52(2):707\u2013717","journal-title":"Biochem Soc Trans"},{"issue":"12","key":"5334_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121605","volume":"14","author":"MA Theodoropoulou","year":"2024","unstructured":"Theodoropoulou MA, Mantzourani C, Kokotos G (2024) Histone deacetylase (HDAC) inhibitors as a novel therapeutic option against fibrotic and inflammatory diseases. Biomolecules 14(12):1605","journal-title":"Biomolecules"},{"issue":"16","key":"5334_CR56","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2020.3308","volume":"323","author":"KK Ray","year":"2020","unstructured":"Ray KK, Nicholls SJ, Buhr KA (2020) Effect of apabetalone added to standard therapy on major adverse cardiovascular events in patients with recent acute coronary syndrome and type 2 diabetes: a randomized clinical trial. JAMA 323(16):1565\u20131573","journal-title":"JAMA"},{"issue":"10","key":"5334_CR57","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s40618-025-02650-0","volume":"48","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang X, Chong N, Chen D, Shu J, Wang R, Wang Q, Xu Y (2025) Dapagliflozin ameliorates high glucose-induced epithelial-mesenchymal transition via up-regulating ACE2 mediated by EZH2 in diabetic nephropathy. J Endocrinol Invest 48(10):2499\u20132509","journal-title":"J Endocrinol Invest"},{"key":"5334_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.938391","volume":"13","author":"Q Hou","year":"2022","unstructured":"Hou Q, Kan S, Wang Z, Shi J, Zeng C, Yang D, Jiang S, Liu Z (2022) Inhibition of HDAC6 with CAY10603 ameliorates diabetic kidney disease by suppressing NLRP3 inflammasome. Front Pharmacol 13:938391","journal-title":"Front Pharmacol"},{"issue":"5","key":"5334_CR59","first-page":"4041","volume":"22","author":"X Sun","year":"2020","unstructured":"Sun X, Sun Y, Lin S, Xu Y, Zhao D (2020) Histone deacetylase inhibitor valproic acid attenuates high glucose-induced endoplasmic reticulum stress and apoptosis in NRK-52E cells. Mol Med Rep 22(5):4041\u20134047","journal-title":"Mol Med Rep"},{"key":"5334_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107306","volume":"207","author":"M Wang","year":"2024","unstructured":"Wang M, Huang Z, Li X, He P, Sun H et al (2024) Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300\/H3K27ac\/PLK1 axis. Pharmacol Res 207:107306","journal-title":"Pharmacol Res"},{"issue":"1","key":"5334_CR61","first-page":"210","volume":"45","author":"Y Du","year":"2020","unstructured":"Du Y, Tang G, Yuan W (2020) Suppression of HDAC2 by sodium butyrate alleviates apoptosis of kidney cells in db\/db mice and HG-induced NRK-52E cells. Int J Mol Med 45(1):210\u2013222","journal-title":"Int J Mol Med"},{"issue":"4","key":"5334_CR62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/13813455.2022.2105365","volume":"130","author":"H Sankrityayan","year":"2024","unstructured":"Sankrityayan H, Kale A, Shelke V, Gaikwad AB (2024) Cyproheptadine, a SET7\/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells. Arch Physiol Biochem 130(4):411\u2013419","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"5334_CR63","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s10753-024-02047-w","volume":"48","author":"Y He","year":"2025","unstructured":"He Y, Xie Y, Zhou T, Li D, Cheng X, Yang P, Luo C, Liu Y, Guo M, Wan Q, Yan P, Gao C, Zhang YY, Sun XD, Xu Y, Huang W (2025) Sodium crotonate alleviates diabetic kidney disease partially via the histone crotonylation pathway. Inflammation 48(1):254\u2013275","journal-title":"Inflammation"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05334-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:03:29Z","timestamp":1786543409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05334-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":63,"alternative-id":["5334"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05334-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"14 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author(s) declared that this work was conducted in the absence of any commercial or financial relations.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors used ChatGPT (OpenAI) solely for language editing and translation refinement during manuscript preparation. No generative AI tools were used for data analysis, interpretation, or generation of scientific conclusions. All final content was reviewed and approved by the authors.","order":2,"name":"Ethics","label":"Generative AI statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}